I. Case presentation
A 45-year old obese multiparous of gravid 2 para 2 (G2P2), perimenopausal lady presented with a mass in the right iliac fossa of one year duration. She had a history of tubectomy 20 years ago. She was not on steroids or hormone replacement therapy .There is no history of gynaecologic interventions. There was no history of seizures, mental retardation, behaviour problems and there were no abnormalities of skin pigmentation Clinical presentation: On Clinical examination lower abdominal distension noted with 16x10 cm oval mass at right iliac fossa. The lump was not moving with respiration, not falling forward on knee elbow position. Renal angles are normal and umbilicus midline everted. Visible infra umbilical vertical midline scar present, no hypertrophy or pigmentation. No shifting of dullness, normal bowel sounds, Left supraclavicular fossa normal. Per vaginal and per rectal examination normal Investigations; Ultrasound abdomen and pelvis showed a large hyper echoic well defined lesion in the posterior wall of uterus suggestive of posterior wall fibroid/ ovarian mass/peritoneal mass. Rest of the visualized visceral organs appears to be normal. MRI: A large well defined circumscribed lobulated soft tissue mass predominantly solid with cystic areas was noted in the right iliac fossa, the mass measuring 14.4x12x6.3 cm may be mesenchymal origin. Intraoperative findings: Laparotomy revealed intra peritoneal minimal fluid collection with a 15 x 11 x 8cms large grayish white well circumscribed solid mass present at right iliac fossa. It was arising from tubectomy scar .Liver, kidney, spleen, ovaries, and uterus and vital organs are normal Management: Excision of mass was done and specimen sent for Histopathological examination. 
Follow-up:
Postoperatively the patient status and general condition improved and uneventful. After repeated follow ups at weekly intervals for first two weeks, monthly intervals for next 3 months, patient recovered completely.
II. Discussion
Leiomyomas are common benign uterine tumours occurring in about 20% to 30% of premenopausal women. 4 The incidence falls sharply in postmenopausal women as it is believed that hormonal changes assist spontaneous resolution of such tumours. Extra uterine leiomyomas are rare events and usually occurs with seeding of myomatous tissues during previous gynaecological surgeries more commonly with laparoscopic procedures. [5] [6] [7] Origin of smooth muscle cell tumours in the anterior abdominal wall from the cells of vessel wall has also been postulated, 8 especially in those receiving hormone replacement therapy. . The alteration of such cells to Leiomyoma involves somatic mutation and unknown synergistic action of hormones, deranged lipoid metabolism and local growth factors.
1,2,4 Progesterone and insulin like growth factors have been implicated in Leiomyoma transformation of a smooth muscle cell. Although lipo-leiomyoma arising from anterior abdominal wall without the presence of above mentioned factors have been reported in a case earlier ,2 but isolated Leiomyoma arising de novo in the anterior abdominal wall muscles has not been reported so far.
Moreover, recently it has been found that adiposite may enhance the proliferation of human Leiomyoma cells via TNF-α pro-inflammatory cytokine that is associated a proliferative gene profile in human uterine Leiomyoma cells may play a role in initiation and/or progression of uterine Leiomyoma (HuLM) cells. 8 The main differential diagnosis of Leiomyoma of the abdominal wall includes well differentiated tumours arising from fat cells, fibrous tissue, and muscle or mesothelial cells. Majority of such tumours are benign. Malignant transformation of smooth muscle tumours have been reported especially in the disseminated variety.9 The diagnosis of de novo Leiomyoma of the anterior abdominal wall can only be made when there is no history of previous abdominal surgery, open or laparoscopic, because the appearance of leiomyomas are known to occur in scars as old as 30 years. 6 In cases where a smooth muscle Leiomyoma has been removed previously irrespective of the route, seeding of the scar has been known to give rise to the formation of the tumour later in life.
Parasitic leiomyomas have been reported in the retro-or pre-peritoneum. It has been proposed that the uterine mass becomes adherent to these structures, develops its own blood supply and gradually over the period of time, it loses attachment with the organ of origin, thus developing as a 'parasite' at the new location. 10, 11 This case is unusual as there are neither antecedent gynaecologic complaints nor any history of gynaecologic surgery in the patient. The only surgery she underwent was a tubectomy 20 years prior to her present complaint. A tubectomy operation giving rise to seeding of a Leiomyoma away from the incision site on the anterior abdominal wall is the point to be considered. If it had arisen in the previous scar, it could have been said, for arguments' sake that smooth muscle cells from the fallopian tubes have been implanted in the scar. So far we have not come across any literature to support our hypothesis of seeding of smooth muscle cell from the fallopian tubes. Every effort should be made to remove the tumour en-block and avoid spillage to prevent the seeding/recurrence of the tumour. In case of a large defect arises after the excision of tumour, synthetic mesh can be used to provide immediate wound cover.
III. Conclusion
A Leiomyoma, although commonly seen in uterus or gastrointestinal tract, can develop de novo in areas devoid of myomatous tissues or obvious smooth muscle cells. Whether smooth muscle cells in vessels of anterior abdominal wall react to extraneous hormonal stimulation to form a de novo Leiomyoma is yet to be established. This condition has to be kept in mind while completing the list of differential diagnosis of anterior abdominal wall tumours. However the smooth muscle cells from the fallopian tubes implanted in the scar as seen in the present case is very rare entity. 
